|
|
News Breaks | | | | January 11, 2013 | | 09:38 EDT |  | SRPT | Sarepta talks with potential partners on DMD drug sales abroad, Bloomberg says
Sarepta Therapeutics' (SRPT) CEO said the company is talking with over a dozen potential partners about international sales of eteplirsen, its drug for Duchenne muscular dystrophy, and may seek advisers to help it select an overseas partner, reported Bloomberg. Reference Link | |
|
News For SRPT From The Last 14 Days Check below for free stories on SRPT the last two weeks. |
|
|
| May 21, 2013 | | 07:34 EDT |  | SRPT | UBS to host a conference
 Subscribe for More Information | | | May 16, 2013 | | 07:29 EDT | | SRPT | Leerink to host a bus tour
Boston Biopharma Bus Tour travels throughout Boston on May 16-17. | | | May 9, 2013 | | 12:21 EDT |  | SRPT | Sarepta climbs after saying documents to be submitted this month
Subscribe for More Information | | | 07:29 EDT |  | SRPT | Sarepta reports Q1 EPS (41c), consensus (62c)
Reports Q1 revenue $4.5M, consensus $5.85M. | |
|
|
|
|
|
|
